Week In Review: Under Pressure From US Congress, WuXi AppTec Resigns From BIO
March 16, 2024 at 15:40 PM EDT
BIO, the global lobbying organization for biotechnology firms, forced WuXi AppTec to leave the group due to pressure from the US Congress. Also, Boehringer Ingelheim acquired an option to license drug candidates that treat symptoms of schizophrenia.
